特他洛爾(英語:Tertatolol),商品名Artex、Artexal、Prenalex,是一種β受體阻滯劑,用於治療高血壓。它是由法國施維雅製藥公司發現的,並在歐洲銷售。[1]
Quick Facts 臨床資料, AHFS/Drugs.com ...
特他洛爾 |
|
AHFS/Drugs.com | 國際藥品名稱 |
---|
給藥途徑 | 口服 |
---|
ATC碼 | |
---|
|
法律規範 |
|
---|
|
(±)-1-(tert-Butylamino)-3-(3,4-dihydro-2H-thiochromen-8-yloxy)propan-2-ol
|
CAS號 | 83688-84-0 Y |
---|
PubChem CID | |
---|
IUPHAR/BPS | |
---|
ChemSpider | |
---|
UNII | |
---|
KEGG | |
---|
ChEMBL | |
---|
CompTox Dashboard (EPA) | |
---|
ECHA InfoCard | 100.073.179 |
---|
|
化學式 | C16H25NO2S |
---|
摩爾質量 | 295.44 g·mol−1 |
---|
3D模型(JSmol) | |
---|
手性 | 外消旋體 |
---|
CC(C)(C)NCC(COC1=CC=CC2=C1SCCC2)O
|
InChI=1S/C16H25NO2S/c1-16(2,3)17-10-13(18)11-19-14-8-4-6-12-7-5-9-20-15(12)14/h4,6,8,13,17-18H,5,7,9-11H2,1-3H3 NKey:HTWFXPCUFWKXOP-UHFFFAOYSA-N N
|
Close
特他洛爾還被證明可作為血清素5-HT1A和5-HT1B受體拮抗劑,類似於普萘洛爾和吲哚洛爾。[2][3][4]
Langlois M, Brémont B, Rousselle D, Gaudy F. Structural analysis by the comparative molecular field analysis method of the affinity of beta-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors. European Journal of Pharmacology. January 1993, 244 (1): 77–87. PMID 8093601. doi:10.1016/0922-4106(93)90061-d.
Jolas T, Haj-Dahmane S, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, et al. (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. May 1993, 347 (5): 453–463. PMID 7686633. S2CID 22129922. doi:10.1007/bf00166735.
van Wijngaarden I, Soudijn W, Tulp MT. 5-HT1A Receptors. Soudijn W, Olivier B, van Wijngaarden I (編). Serotonin Receptors and Their Ligands. Amsterdam: Elsevier. 1997. ISBN 0-444-82041-8.
Template:Navbox with collapsible groups